Back to Awarded Treatment Trials
Awarded Trial: 01T-076
Grant ID
01T-076
Illness
Schizophrenia
Primary Drug/Intervention
Reboxetine
Primary Dosage
4mg-8mg
Secondary Drug Intervention
Citalopram
Secondary Dosage
20mg-40mg
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Terminated
Investigator
Raedler
Sample Size
75
Duration of Study Period for Each Subject
4 weeks
Outcome Measurements
PANSS, CGI, HAM-D, Calgary Depression Scale, Subjective Well Being, Social Adaptation Self-evaluation Scale
Results
Grant terminated due to slow enrollment.
Publication
N/A
Link
N/A
PI Name
Thomas Raedler
Degree
MD
Center
Department of Psychiatry
Institution
University Hospital Hamburg-Eppendorf
Address
Martinistr. 52
City or Town
Hamburg
State or Province
N/A
Zip or Postal Code
20246
Country
Germany
Email Address
traedler@uke.uni-hamburg.de